Ding DN - Search Results

1

Icariin as a potential anticancer agent: a review of its biological effects on various cancers.

Liu FY, Ding DN, Wang YR, Liu SX, Peng C, Shen F, Zhu XY, Li C, Tang LP, Han FJ. Liu FY, et al. Among authors: ding dn. Front Pharmacol. 2023 Jun 30;14:1216363. doi: 10.3389/fphar.2023.1216363. eCollection 2023. Front Pharmacol. 2023. PMID: 37456751 Free PMC article. Review.

2

Complementary and Alternative Medicine for Dysmenorrhea Caused by Endometriosis: A Review of Utilization and Mechanism.

Guo Y, Liu FY, Shen Y, Xu JY, Xie LZ, Li SY, Ding DN, Zhang DQ, Han FJ. Guo Y, et al. Among authors: ding dn. Evid Based Complement Alternat Med. 2021 Jul 2;2021:6663602. doi: 10.1155/2021/6663602. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34306150 Free PMC article. Review.

3

Insights into the Role of Oxidative Stress in Ovarian Cancer.

Ding DN, Xie LZ, Shen Y, Li J, Guo Y, Fu Y, Liu FY, Han FJ. Ding DN, et al. Oxid Med Cell Longev. 2021 Oct 7;2021:8388258. doi: 10.1155/2021/8388258. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34659640 Free PMC article. Review.

4

Complementary and Alternative Medicine for Premature Ovarian Insufficiency: A Review of Utilization and Mechanisms.

Fu Y, Ding DN, Shen Y, Jia LY, Yan MY, Wei W, Song CH, Han FJ. Fu Y, et al. Among authors: ding dn. Evid Based Complement Alternat Med. 2022 Apr 1;2022:9053930. doi: 10.1155/2022/9053930. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35399635 Free PMC article. Review.

5

The role of vaginal microecology in the cervical cancer.

Wei W, Xie LZ, Xia Q, Fu Y, Liu FY, Ding DN, Han FJ. Wei W, et al. Among authors: ding dn. J Obstet Gynaecol Res. 2022 Sep;48(9):2237-2254. doi: 10.1111/jog.15359. Epub 2022 Jul 11. J Obstet Gynaecol Res. 2022. PMID: 35815344 Review.

6

Research progress on traditional Chinese medicine-induced apoptosis signaling pathways in ovarian cancer cells.

Wang Y, Xie L, Liu F, Ding D, Wei W, Han F. Wang Y, et al. J Ethnopharmacol. 2024 Jan 30;319(Pt 2):117299. doi: 10.1016/j.jep.2023.117299. Epub 2023 Oct 8. J Ethnopharmacol. 2024. PMID: 37816474 Review.

7

[Advances in mechanism of traditional Chinese medicine in inhibiting angiogenesis in ovarian cancer].

Tang MY, Ding DN, Xie YY, Shen F, Li J, Liu FY, Han FJ. Tang MY, et al. Among authors: ding dn. Zhongguo Zhong Yao Za Zhi. 2023 Dec;48(24):6572-6581. doi: 10.19540/j.cnki.cjcmm.20230712.704. Zhongguo Zhong Yao Za Zhi. 2023. PMID: 38212017 Review. Chinese.

8

Exploring the causal role of multiple metabolites on ovarian cancer: a two sample Mendelian randomization study.

Liu S, Ding D, Liu F, Guo Y, Xie L, Han FJ. Liu S, et al. J Ovarian Res. 2024 Jan 23;17(1):22. doi: 10.1186/s13048-023-01340-w. J Ovarian Res. 2024. PMID: 38263045 Free PMC article.

9

Expression and clinical significance of miR-204 in patients with hypertensive disorder complicating pregnancy.

He X, Ding DN. He X, et al. Among authors: ding dn. BMC Pregnancy Childbirth. 2022 Mar 7;22(1):182. doi: 10.1186/s12884-022-04501-9. BMC Pregnancy Childbirth. 2022. PMID: 35255856 Free PMC article.

10

High miR-200a-3p expression has high diagnostic values for hypertensive disorders complicating pregnancy and predicts adverse pregnancy outcomes.

He X, Ding D. He X, et al. BMC Pregnancy Childbirth. 2022 Jun 15;22(1):490. doi: 10.1186/s12884-022-04785-x. BMC Pregnancy Childbirth. 2022. PMID: 35705894 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page